Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Coherus Bio (CHRS)

Coherus Bio (CHRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Essent Group Set to Join S&P MidCap 400; Coherus BioSciences, Patterson-UTI Energy to Join S&P SmallCap 600

, /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on :

CHRS : 18.64 (+2.14%)
ESNT : 33.05 (-2.07%)
NE : 0.1300 (-10.71%)
OPB : 19.49 (-2.35%)
PPBI : 21.62 (-2.70%)
PTEN : 3.69 (-13.79%)
SPGI : 325.02 (+1.95%)
10.8% Return Seen to Date on SmarTrend Coherus Bioscien Call (CHRS)

SmarTrend identified an Uptrend for Coherus Bioscien (NASDAQ:CHRS) on March 24th, 2020 at $15.00. In approximately 2 months, Coherus Bioscien has returned 10.80% as of today's recent price of $16.62.

CHRS : 18.64 (+2.14%)
Coherus BioSciences Reports First Quarter 2020 Financial Results

- First Quarter UDENYCA(R) Net Sales of $116.2 Million -

CHRS : 18.64 (+2.14%)
Shares of CHRS Up 6.1% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Coherus Bioscien (NASDAQ:CHRS) on March 24th, 2020 at $15.00. In approximately 1 month, Coherus Bioscien has returned 6.13% as of today's recent price of $15.92.

CHRS : 18.64 (+2.14%)
Coherus BioSciences Management to Present at BofA Securities 2020 Health Care Conference

Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS), today announced that senior management will make a virtual presentation at BofA Securities 2020 Health Care Conference on Thursday, May 14, 2020 at...

CHRS : 18.64 (+2.14%)
Coherus BioSciences (CHRS) Earnings Expected to Grow: Should You Buy?

Coherus BioSciences (CHRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CHRS : 18.64 (+2.14%)
Coherus BioSciences to Report First Quarter Financial Results on May 7th

Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced that its first quarter 2020 financial results will be released after market close on Thursday, May 7, 2020. Starting...

CHRS : 18.64 (+2.14%)
Watch for Coherus Bioscien to Potentially Pullback After Gaining 5.41% Yesterday

Coherus Bioscien (NASDAQ:CHRS) traded in a range yesterday that spanned from a low of $15.22 to a high of $16.49. Yesterday, the shares gained 5.4%, which took the trading range above the 3-day high...

CHRS : 18.64 (+2.14%)
Check These 7 Top-Ranked Stocks With Solid Net Profit Margins

Let's take a look at the seven top-ranked stocks with impressive net profit margins for a winning portfolio.

CBZ : 22.65 (-2.08%)
BSTC : 62.20 (-2.39%)
ROCK : 44.01 (+0.80%)
DHT : 5.94 (-1.00%)
CHRS : 18.64 (+2.14%)
EURN : 10.12 (-0.20%)
ITGR : 79.18 (-0.79%)
Coherus BioSciences Prices $200.0 Million Convertible Senior Subordinated Notes Offering

Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced the pricing of its offering of $200,000,000 aggregate principal amount of 1.500% convertible senior subordinated notes...

CHRS : 18.64 (+2.14%)
Coherus Bioscien Shares Up -1.8% Since SmarTrend's Buy Recommendation (CHRS)

SmarTrend identified an Uptrend for Coherus Bioscien (NASDAQ:CHRS) on March 24th, 2020 at $15.00. In approximately 3 weeks, Coherus Bioscien has returned 1.80% as of today's recent price of $14.73.

CHRS : 18.64 (+2.14%)
Coherus Bioscien Falls 7.01% on Heavy Volume: Watch For Potential Rebound

Coherus Bioscien (NASDAQ:CHRS) traded in a range yesterday that spanned from a low of $14.43 to a high of $15.15. Yesterday, the shares fell 7.0%, which took the trading range below the 3-day low of...

CHRS : 18.64 (+2.14%)
Coherus BioSciences Announces Proposed Convertible Senior Subordinated Notes Offering

Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced its intention to offer, subject to market and other conditions, $200,000,000 aggregate principal amount of convertible...

CHRS : 18.64 (+2.14%)
Coherus BioSciences Provides First Quarter 2020 Financial Update and Fiscal Year 2020 COVID-19 Impact Insights

Coherus BioSciences, Inc. ("Coherus" or "the Company", Nasdaq: CHRS), today announced preliminary unaudited revenue for UDENYCA and net income for the quarter ended March 31, 2020. Coherus also provided...

CHRS : 18.64 (+2.14%)
The Zacks Analyst Blog Highlights: AbbVie, Coherus BioSciences, Bluerock Residential Growth REIT, Huntington Ingalls Industries and Installed Building Products

The Zacks Analyst Blog Highlights: AbbVie, Coherus BioSciences, Bluerock Residential Growth REIT, Huntington Ingalls Industries and Installed Building Products

BRG : 6.43 (-3.60%)
HII : 199.89 (-0.39%)
ABBV : 92.67 (+2.93%)
IBP : 64.28 (-2.69%)
CHRS : 18.64 (+2.14%)
Signs of Coronavirus Slowdown Pep Up Wall Street: 5 Winners

Wall Street continues to build on a steep rebound in the previous session after lockdown strategy stabilized coronavirus outbreak in the United States and abroad.

BRG : 6.43 (-3.60%)
HII : 199.89 (-0.39%)
ABBV : 92.67 (+2.93%)
IBP : 64.28 (-2.69%)
CHRS : 18.64 (+2.14%)
Stocks Soar Over 7% on Hopes that the Spread is Slowing

Stocks Soar Over 7% on Hopes that the Spread is Slowing

HAIN : 31.48 (+3.03%)
CHRS : 18.64 (+2.14%)
AGN : 193.02 (+0.02%)
AAWW : 39.06 (+0.41%)
BAH : 79.76 (+1.30%)
BMY : 59.72 (-0.15%)
DG : 191.51 (+4.02%)
NDAQ : 118.46 (+1.80%)
TQQQ : 82.77 (+4.13%)
UPRO : 42.97 (+1.18%)
USFD : 19.14 (-1.34%)
AGYS : 19.23 (-1.03%)
Is Coherus BioSciences (CHRS) Stock a Solid Choice Right Now?

Coherus BioSciences (CHRS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

CHRS : 18.64 (+2.14%)
Market Still Sliding While Waiting For Congress

Market Still Sliding While Waiting For Congress

RSG : 85.46 (+0.67%)
EBAY : 45.54 (+2.96%)
FG : 8.34 (+7.47%)
TXRH : 51.85 (-0.31%)
PFSI : 33.58 (+0.45%)
AAWW : 39.06 (+0.41%)
CHRS : 18.64 (+2.14%)
PDCO : 19.69 (-1.50%)
HAIN : 31.48 (+3.03%)
XEL : 65.03 (+1.59%)
CAMT : 12.89 (+1.10%)
TDOC : 174.06 (+4.29%)
Coherus Bioscien has the Best Relative Performance in the Biotechnology Industry (CHRS , BLUE , TGTX , ARWR, AMAG )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

BLUE : 63.63 (+4.64%)
CHRS : 18.64 (+2.14%)
TGTX : 18.65 (-5.52%)
ARWR : 32.24 (-2.57%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.79 , SEDG +6.61 , THC -1.40 , TER +2.46 , LITE +1.03
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar